Bacil Pharma share news and announcements
BSE: 524516Pharmaceuticals & BiotechnologySmall Cap
Last close ₹19.98down ₹0.46 (2.25%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹20.44.
52-week range of traded prices to 23 Oct 2026
₹10.65Low, 26 Aug 2026₹61.80High, 10 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29 Cr3,172nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 Oct 2026
- 1.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Oct 2026
- −0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. The filing of 14 Oct 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 5,940
Bacil Pharma board meetings
152 filed, newest first. Page 1 of 4.
Oct 2026
5 Oct · Board meeting
Meeting on 14 Oct 2026: quarterly results
Aug 2026
29 Aug · Board meeting
26 Aug · Board meeting
Meeting on 29 Aug 2026: annual general meeting25 Aug · Board meeting
18 Aug · Board meeting
Meeting on 25 Aug 20266 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
Jul 2026
9 Jul · Board meeting
3 Jul · Board meeting
Meeting on 9 Jul 2026
Jun 2026
26 Jun · Board meeting
23 Jun · Board meeting
Meeting on 26 Jun 2026: preferential issue of shares and rights issue
May 2026
11 May · Board meeting
Meeting on 22 May 2026: audited results
Feb 2026
5 Feb · Board meeting
Meeting on 13 Feb 2026: quarterly results
Nov 2025
6 Nov · Board meeting
Meeting on 13 Nov 2025: quarterly results
Sep 2025
5 Sep · Board meeting
2 Sep · Board meeting
Meeting on 5 Sep 2025
Aug 2025
27 Aug · Board meeting
19 Aug · Board meeting
Meeting on 25 Aug 20255 Aug · Board meeting
Meeting on 12 Aug 2025: quarterly results
Jul 2025
16 Jul · Board meeting
11 Jul · Board meeting
Meeting on 16 Jul 2025
May 2025
19 May · Board meeting
Meeting on 26 May 2025: audited results
Mar 2025
12 Mar · Board meeting
Meeting on 12 Mar 2025: preferential issue of shares
Jan 2025
13 Jan · Board meeting
Meeting on 21 Jan 2025: quarterly results
Oct 2024
23 Oct · Board meeting
23 Oct · Board meeting
16 Oct · Board meeting
Meeting on 23 Oct 2024: quarterly results15 Oct · Board meeting